Key Insights

Highlights

Success Rate

85% trial completion

Published Results

55 trials with published results (28%)

Research Maturity

106 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

9.5%

19 terminated out of 199 trials

Success Rate

84.8%

-1.8% vs benchmark

Late-Stage Pipeline

14%

27 trials in Phase 3/4

Results Transparency

52%

55 of 106 completed with results

Key Signals

55 with results85% success19 terminated

Data Visualizations

Phase Distribution

160Total
Not Applicable (120)
P 1 (2)
P 2 (11)
P 3 (10)
P 4 (17)

Trial Status

Completed106
Unknown31
Terminated19
Recruiting17
Active Not Recruiting14
Not Yet Recruiting6

Trial Success Rate

84.8%

Benchmark: 86.6%

Based on 106 completed trials

Clinical Trials (199)

Showing 20 of 20 trials
NCT06053606Not ApplicableActive Not RecruitingPrimary

The Impact of Expandable Cryoballoon on Autonomic Control of the Heart

NCT06223789Not ApplicableCompleted

VOLT-AF IDE Clinical Study

NCT07116525Not ApplicableRecruiting

A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

NCT05988411Not ApplicableActive Not RecruitingPrimary

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

NCT06431815Active Not RecruitingPrimary

ADVENT Post Approval Study

NCT06170606Not ApplicableCompletedPrimary

POLARx Post Approval Study (POLARx PAS)

NCT07444320Not ApplicableRecruitingPrimary

Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System

NCT04704986Phase 4CompletedPrimary

Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF

NCT05227053RecruitingPrimary

STOP AF First Post-Approval Study

NCT07714876Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation

NCT04088071RecruitingPrimary

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

NCT06895187Not Yet RecruitingPrimary

Catheter Ablation Using a Novel Navigation and Imaging System

NCT07686328Not ApplicableNot Yet RecruitingPrimary

A Multicenter Feasibility Study With the VERAFEYE Imaging and Guidance System as Anatomical Navigation System

NCT05230524TerminatedPrimary

DIAMOND AF Post-Approval Study

NCT03963349Active Not RecruitingPrimary

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study

NCT05085860Not ApplicableCompleted

Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation

NCT05996159Not ApplicableRecruitingPrimary

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

NCT04529785Not ApplicableRecruitingPrimary

Added Value of Vein of Marshal Ethanol Infusion Compared to Superior Vena Cava Isolation Alone in Patients Undergoing Repeat Ablation for Recurrent Paroxysmal Atrial Fibrillation Despite Durable PV Isolation

NCT06106594Not ApplicableActive Not Recruiting

VOLT CE Mark Study

NCT07535268Recruiting

REPRESENT-PF Registry

Scroll to load more

Research Network

Activity Timeline